GVR Report cover Protein Detection and Quantification Market Size, Share and Trends Report

Protein Detection and Quantification Market Size, Share and Trends Analysis Report By Technology (Immunological Methods, Chromatography, Mass Spectrometry), By Products, By Applications, By End-use, And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-1-68038-504-5
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Industry Insights

The global protein detection & quantification market size was estimated at USD 1.48 billion in 2016. Detection and quantification of proteins is a crucial step for understanding post-translational modifications as these aid in deciphering the functions of complicated peptide networks for application in cell biology and medicine.

Rising demand for protein quantification in laboratories that deal with versatile activities ranging from protein characterization to clinical diagnostic testing and drug dosing is anticipated to impact industrial growth in the coming years. Selection of an appropriate technology out of a large number of available methods of quantitation for the kind of protein to be detected and its concentration in the sample remains an important step in biotechnology protocols.

Germany protein detection & quantification market by end-use, 2014 - 2025 (USD Million)

Germany protein detection & quantification market

Proteomics offers opportunities for stratification, diagnosis, and disease monitoring. The assay has to meet specific requirements in order to be clinically useful. The development of such sensitive tests is anticipated to fuel growth in the proteomics market thus leading to growth in the protein detection and quantification market.

Many techniques of proteomics exist to link biologic function and proteins, for example, mammalian two-hybrid system and yeast two-hybrid system to study the inter-protein interactions by gel shift assay. Furthermore, protein-chip technology, ELISA, one- or two- dimensional gel electrophoresis, and mass spectroscopy are instruments witnessing continuous advancements.

Furthermore, proteomic studies carried out on for finding the mechanism of physical and chemical degradation pathways of biologics are anticipated to propel progress. In addition to advancements, the development of next-generation techniques for the protein concentration estimation is expected to drive the market with potential avenues.

FTIR based spectrometer provides a new methodology of protein quantification and enables high accurate IR based examination of amide bonds in protein chains without focusing on other factors such as redox potential dye binding properties, and amino acid composition. Moreover, the direct detection system utilizes approximately two microliters of sample and takes two to three minutes to finish the test, enhancing the adoption of advanced products and thus contributing to the sector growth.

Technology Insights

Colorimetry accounted for the largest share with respect to revenue generation as a result of the higher use of this technique, due to its convenience rate and wide availability of the reagents for its implementation. Immunological methods are expected to witness the fastest growth due to the introduction of advancement in this segment.

In April 2017, MilliporeSigma launched a new Single Molecule Counting Platform, termed SMCxPROTM, during the American Association for Cancer Research annual meet. The SMCxPRO platform is based on the principle of immunoassay and it enables precise and sensitive detection over the conventional methods.

This novel technology is anticipated to enable researchers for detection and monitoring changes in the biomarker concentration, down to a femtogram level, with scope to increase the limit of detection with further fine-tuning down the line. Such technological advances are anticipated to propel growth in this industry.

Product Insights

Products employed include assay kits (BCA assay, Bradford assay Lowery assay), biological stains, reagents, sampling devices, and disposables. Low pricing, enhanced functionalities, and wide applicability are some of the latest advancements in the consumables segment. These advancements are attributive to the estimated revenue share of over 64% in 2016.

Launch of novel equipment is anticipated to drive growth with potential avenues in the instrument segment in the coming years. Introduction of next-generation protein detection technologies such as FTIR, longitudinal assay screening, and the other immunoassay platforms are anticipated to serve as a fillip to revenue generation.

Application Insights

Quantitative estimation of the protein is applicable in several research areas including drug discovery & development, clinical diagnosis of acute as well as chronic diseased states, food and animal feed testing, and environmental & agricultural applications.

Government and public-private partnerships that are intended towards developing advancements in novel drug molecule discovery are supportive for the largest share of the segment with respect to revenue in 2016.

Furthermore, various candidate biomarkers developed through proteomics and genomics research have the potential to serve as predictive indexes for producing safer and more effective drugs. In the discovery stage, differential proteomic analysis with the help of mass spectrometry enables the recognition of candidates which are linked with a specific mechanism relevant to disease progression and affected by drug treatment.

Incorporation of informative biomarkers as predictive tools in clinical trials is increasingly viewed for not only enabling smarter decisions but also as a resource investment for the development of potential diagnostics. The aforementioned fact is anticipated to drive the clinical diagnostics segment with the fastest rate.

Development of convenient as well as innovative assays that can fit-for-purpose and, match the specific requirements represents a significant challenge with regards to the technical aspects of the antibody as well as assay designing. This fact is expected to drive the proteomics studies potentially.

End-use Insights

Escalating usage of these amino acid biomolecules in various applications such as clinical diagnosis for detection and development of therapy against disorders, food processing industries, and agriculture biotechnology is generating demand for efficient peptide estimation methods.

End-users for these technologies comprise academic research institutes, contract research organizations, and pharmaceutical & biotechnology companies. Companies and research institutes working in this field are engaged in the provision of precise and innovative products that are expected to drive this market in the future. Application of the solutions in research projects that are carried out in the universities and research centers is attributive to the estimated revenue share of the segment.

Study on enzymatic digestion of peptides in gels by mass spectrometry and structural analysis supported by Yale University School of Medicine, explaining the role of enzymatic digestion technique in protein concentration estimation is expected to drive the growth of the segment in the coming years.

Protein Detection & Quantification Market, By Region, 2016 (%)

Protein detection & quantification market

Regional Insights

North America dominated with respect to revenue generation in 2016; particularly the U.S. held a major share of revenue owing to the presence of major players in the region coupled with a well-established healthcare framework in the region. However, Asia Pacific is expected to emerge as the fastest-growing region due to emerging economies such as China and India.

The U.S. is amongst the key market for this market. A combination of factors such as developed infrastructure, an increase in R&D investment, and growing cases of various diseases in the region are the factors attributed to the market growth in the U.S.

Continuous efforts of government and top-notch private firms in novel drug discovery and development are expected to impact proteomics growth in this country. For instance, recently researchers at The Scripps Research Institute (TSRI) have developed a new toolkit that enables them to discover and reveal the new functional characteristics of peptide biomolecules. They have developed new probes based on activity-based peptide -profiling (ABPP) for the detection of potential drug targets.

Competitive Insights

Some of the key players in the market are Merck & Co., Inc., Danaher, RayBiotech, Inc., Inanovate, Shimadzu Corporation, PerkinElmer Inc, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, and GE Healthcare. Companies are engaged in proactive optimization of business mix and portfolios.

These companies are focusing on the production of novel products based on the upcoming technologies in order to maintain the market share. Strong competition between the established market entities for the launch of novel techniques is anticipated to fuel progress.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2016

Forecast period

2017 - 2025

Market representation

Revenue in USD Million & CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, U.K., Germany, Japan, China, Brazil, South Africa.

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at the regional & country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this report, Grand View Research has segmented the protein detection & quantification market on the basis of technology, product, application, end-use, and regions:

  • Technology Outlook (Revenue, USD Million; 2014 - 2025)

    • Colorimetric Assays

    • Immunological Methods

    • Chromatography

    • Mass Spectrometry

    • Spectroscopy Instruments

    • Others

  • Product Outlook (Revenue, USD Million; 2014 - 2025)

    • Kits & Reagents/Consumables

    • Instruments

    • Services

  • Application Outlook (Revenue, USD Million; 2014 - 2025)

    • Drug Discovery & Development

    • Clinical Diagnosis

    • Others

  • End-use Outlook (Revenue, USD Million; 2014 - 2025)

    • Academic Research Institutes

    • Biotechnology & Pharmaceutical Companies

    • Contract Research Organization

    • Others

  • Regional Outlook (Revenue, USD Million; 2014 - 2025)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The U.K.

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

    • The Middle East and Africa (MEA)

      • South Africa

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.